Questcor Pharmaceuticals (QCOR) Jumps Higher on Analyst Defense

July 13, 2012 2:00 PM EDT Send to a Friend
Questcor Pharmaceuticals (Nasdaq: QCOR) is bouncing again on word analysts at BofA have confirmed that the company threatening to develop a generic form of ACTH is fraudulent.

While still down 3.4 percent, these comments are moving shares higher - something the earlier company JMP presentation was unable to do.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Trader Talk

Related Entities

Bank of America

Add Your Comment